| Dr Jaime Luis Torres Ii, MD | |
|
6279 N Lecanto Hwy, Beverly Hills, FL 34465-2503 | |
| (352) 522-0094 | |
| (352) 522-0098 |
| Full Name | Dr Jaime Luis Torres Ii |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 6279 N Lecanto Hwy, Beverly Hills, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174592638 | NPI | - | NPPES |
| 014708000 | Medicaid | FL | |
| 150K5 | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 12707 (Hawaii) | Secondary |
| 207R00000X | Internal Medicine | ME123151 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Access Health Care Physicians Llc | 4385821156 | 190 |
News Archive
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University.
The Wall Street Journal reports on the criticism emanating from the left regarding the Senate health bill. "Former Vermont Gov. Howard Dean is mounting a campaign of sorts against the initiative in its current form.
People who suffer neglect and abuse in childhood are much more likely to have time off work due to long-term sickness and less likely to own their own homes when they reach middle age than their peers, according to new research undertaken at UCL.
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
› Verified 6 days ago
| Entity Name | Access Health Care Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245529742 PECOS PAC ID: 4385821156 Enrollment ID: O20110602000715 |
News Archive
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University.
The Wall Street Journal reports on the criticism emanating from the left regarding the Senate health bill. "Former Vermont Gov. Howard Dean is mounting a campaign of sorts against the initiative in its current form.
People who suffer neglect and abuse in childhood are much more likely to have time off work due to long-term sickness and less likely to own their own homes when they reach middle age than their peers, according to new research undertaken at UCL.
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jaime Luis Torres Ii, MD 14690 Spring Hill Dr, Ste 305, Spring Hill, FL 34609-8102 Ph: (352) 277-5348 | Dr Jaime Luis Torres Ii, MD 6279 N Lecanto Hwy, Beverly Hills, FL 34465-2503 Ph: (352) 522-0094 |
News Archive
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University.
The Wall Street Journal reports on the criticism emanating from the left regarding the Senate health bill. "Former Vermont Gov. Howard Dean is mounting a campaign of sorts against the initiative in its current form.
People who suffer neglect and abuse in childhood are much more likely to have time off work due to long-term sickness and less likely to own their own homes when they reach middle age than their peers, according to new research undertaken at UCL.
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
› Verified 6 days ago
Dr. Bhadresh K Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3775 N Lecanto Hwy, Beverly Hills, FL 34465 Phone: 352-746-0600 Fax: 352-746-0607 | |
Mr. Venugopala A Reddy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3400 N Lecanto Hwy, Suite A, Beverly Hills, FL 34465 Phone: 352-746-2227 Fax: 352-746-3587 | |
Mr. Mariananda P Kumar, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3400 N Lecanto Hwy, Suite A, Beverly Hills, FL 34465 Phone: 352-746-2227 Fax: 352-746-3587 | |
Jennifer Delatola, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3775 N Lecanto Hwy, Beverly Hills, FL 34465 Phone: 352-746-0600 | |
Mr. Alexander Ong Liu Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 West Lemon Street, Beverly Hills, FL 34465 Phone: 352-746-2525 Fax: 352-746-4141 |